Inventor

MORROW MATTHEW P

US15 patents

⚠️ This page may combine multiple inventors who share the name “MORROW MATTHEW P”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

UNIV PENNSYLVANIA

12 patents

US9981036B2May 29, 2018

Compositions, comprising improved Il-12 genetic constructs and vaccines, immunotherapeutics and methods of using the same

UNIV PENNSYLVANIA6 citations84

US9272024B2Mar 1, 2016

Compositions, comprising improved IL-12 genetic constructs and vaccines, immunotherapeutics and methods of using the same

UNIV PENNSYLVANIA9 citations84

US9750795B2Sep 5, 2017

Proteins comprising MRSA PBP2a and fragments thereof, nucleic acids encoding the same, and compositions and their use to prevent and treat MRSA infections

UNIV PENNSYLVANIA8 citations83

US12280108B2Apr 22, 2025

Vaccines having an antigen and interleukin-21 as an adjuvant

UNIV PENNSYLVANIA0 citations62

US11241496B2Feb 8, 2022

Compositions, comprising improved IL-12 genetic constructs and vaccines, immunotherapeutics and methods of using the same

UNIV PENNSYLVANIA0 citations62

US11007265B2May 18, 2021

Vaccines having an antigen and interleukin-21 as an adjuvant

UNIV PENNSYLVANIA0 citations62

US10980870B2Apr 20, 2021

Proteins comprising MRSA Pbp2a and fragments thereof, nucleic acids encoding the same, and compositions and their use to prevent and treat MRSA infections

UNIV PENNSYLVANIA0 citations62

US9192660B2Nov 24, 2015

Proteins comprising MRSA PBP2a and fragments thereof, nucleic acids encoding the same, and compositions and their use to prevent and treat MRSA infections

UNIV PENNSYLVANIA0 citations51

WEINER DAVID B

2 patents

US8298820B2Oct 30, 2012

Influenza nucleic acid molecules and vaccines made therefrom

WEINER DAVID B7 citations84

US10071154B2Sep 11, 2018

Vaccines and immunotherapeutics using IL-28 and compositions and methods of using the same

WEINER DAVID B2 citations72

INOVIO PHARMACEUTICALS INC

1 patent

US12350318B2Jul 8, 2025

Combination therapy to treat brain cancer

INOVIO PHARMACEUTICALS INC0 citations42

MORROW MATTHEW P

UNIV PENNSYLVANIA

Compositions, comprising improved Il-12 genetic constructs and vaccines, immunotherapeutics and methods of using the same

Compositions, comprising improved IL-12 genetic constructs and vaccines, immunotherapeutics and methods of using the same

Proteins comprising MRSA PBP2a and fragments thereof, nucleic acids encoding the same, and compositions and their use to prevent and treat MRSA infections

Vaccines having an antigen and interleukin-21 as an adjuvant

Compositions, comprising improved IL-12 genetic constructs and vaccines, immunotherapeutics and methods of using the same

Vaccines having an antigen and interleukin-21 as an adjuvant

Proteins comprising MRSA Pbp2a and fragments thereof, nucleic acids encoding the same, and compositions and their use to prevent and treat MRSA infections

Influenza nucleic acid molecules and vaccines made therefrom

Influenza nucleic acid molecules and vaccines therefrom

Influenza nucleic acid molecules and vaccines made therefrom

Vaccines having an antigen and interleukin-21 as an adjuvant

Proteins comprising MRSA PBP2a and fragments thereof, nucleic acids encoding the same, and compositions and their use to prevent and treat MRSA infections

WEINER DAVID B

Influenza nucleic acid molecules and vaccines made therefrom

Vaccines and immunotherapeutics using IL-28 and compositions and methods of using the same

INOVIO PHARMACEUTICALS INC

Combination therapy to treat brain cancer